Aktiesnakken — August 2012
-
Genmab: Ofatumumab i nyt fase 3, http://clinicaltrials.gov/ct2/show/NCT01659021?term=ofatumumab&rank=44
-
-
industriproduktionen i tyskland var også noget crap
-
-
flot SPPI regnskab
-
skuffer mig lidt på omsætning. Men generelt et OK flot resultat
-
linket går til bedford laboratories
-
-
her sorry
-
hvordan matcher fusi WK data?
-
ser jo ikke vild dyr med den vækst
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind